Is Neuroendocrine Tumor Research Foundation Legit?

Quick charity verification for Neuroendocrine Tumor Research Foundation (EIN: 201945347)

Verdict: Neuroendocrine Tumor Research Foundation appears trustworthy

92/100Mission Score
$5.3MRevenue
$21.4MAssets
2Red Flags
4Strengths

Red Flags

Strengths

Spending Breakdown

How Neuroendocrine Tumor Research Foundation allocates its funds across programs, administration, and fundraising.

90%
Program Spending
Healthy — majority goes to mission
7%
Admin Costs
Reasonable — admin costs in check
3%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.

How to Interpret This Report

What Red Flags Mean

Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.

What Mission Score Measures

The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.

Using This Data for Donation Decisions

Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.

Frequently Asked Questions about Neuroendocrine Tumor Research Foundation

Is Neuroendocrine Tumor Research Foundation a legitimate charity?

Based on AI analysis of IRS 990 filings, Neuroendocrine Tumor Research Foundation (EIN: 201945347) appears trustworthy. Mission Score: 92/100. 2 red flags identified, 4 strengths noted.

Is Neuroendocrine Tumor Research Foundation a good charity to donate to?

Neuroendocrine Tumor Research Foundation has a Mission Score of 92/100. Revenue: $5.3M. Assets: $21.4M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.

What is the EIN for Neuroendocrine Tumor Research Foundation?

The Employer Identification Number (EIN) for Neuroendocrine Tumor Research Foundation is 201945347. This is the unique tax ID assigned by the IRS.

What is a Mission Score?

The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.

How does Neuroendocrine Tumor Research Foundation spend its money?

Neuroendocrine Tumor Research Foundation allocates 90% to programs, 7% to administration, and 3% to fundraising. Healthy nonprofits typically spend 75%+ on programs.

How can I verify Neuroendocrine Tumor Research Foundation's tax-exempt status?

You can verify Neuroendocrine Tumor Research Foundation's tax-exempt status using EIN 201945347 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.

AI Transparency Report

The Neuroendocrine Tumor Research Foundation demonstrates a generally stable financial position with significant assets relative to its annual expenses. While revenue has fluctuated, notably a peak in 2015 and 2021, the organization consistently maintains substantial assets, reaching $21,377,613 in the latest filing. The absence of reported officer compensation across all filings suggests a strong commitment to directing funds towards its mission, enhancing its transparency and public trust. However, the organization has experienced periods where expenses exceeded revenue, such as in 2023, 2022, 2019, 2018, and 2017, indicating reliance on prior year surpluses or asset drawdowns during those specific years. Spending efficiency appears strong given the zero officer compensation, implying that administrative costs are likely kept low, allowing a greater proportion of funds to be allocated to program services. The consistent growth in assets over the long term, despite some years of operational deficits, suggests effective financial management and investment strategies. The organization's transparency is further bolstered by its consistent filing history and the clear indication of no executive compensation, which is a significant positive indicator for donors. Overall, the Neuroendocrine Tumor Research Foundation appears to be a financially sound organization with a strong commitment to its mission, as evidenced by its asset base and lack of executive compensation. While revenue can be volatile, its substantial assets provide a buffer, and the consistent filing of IRS 990s demonstrates a commitment to transparency. Donors can be reasonably confident in the organization's ability to manage funds effectively and direct them towards its stated goals.

View Full Transparency Report →

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Related Pages